Ubs Group Ag Atossa Therapeutics, Inc. Put Options Transaction History
Ubs Group Ag
- $555 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ATOS
# of Institutions
87Shares Held
28.6MCall Options Held
12.7KPut Options Held
92.9K-
Black Rock Inc. New York, NY9.2MShares$7.08 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.83MShares$4.49 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN2.97MShares$2.29 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.05MShares$1.58 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.81MShares$1.4 Million0.0% of portfolio
About ATOSSA THERAPEUTICS, INC.
- Ticker ATOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,624,000
- Market Cap $97.5M
- Description
- Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...